Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06582719 · ClinicalTrials.gov registry record · NA
Evaluating the Efficacy of GPT-based Nutrition and Diabetic Counseling in Gestational Diabetes Management: A Randomized Controlled Trial (AIM-GDM)
A NA study of Gestational Diabetes, sponsored by Montefiore Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT06582719: Recruiting NA study of Gestational Diabetes, sponsored by Montefiore Medical Center.
NCT06582719 is a NA study of Gestational Diabetes that is actively recruiting participants, run by Montefiore Medical Center. The registered enrollment target is 80 participants, below the 320-participant average among 41 other Gestational Diabetes trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06582719, a NA study of Gestational Diabetes, is actively recruiting participants, sponsored by Montefiore Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess whether an AI based counseling service can be beneficial for patients to assist in management of gestational diabetes.
Conditions Studied
Interventions
- DEVICE GPT-based counseling
- OTHER Nutritional Counseling
Study Locations (1)
New York
- Montefiore Medical Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-05-29 |
| Est. Completion | 2027-01 |
| Phase | NA |
What NCT06582719 shows while recruiting
NCT06582719 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 320-participant average among 41 other Gestational Diabetes trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Gestational Diabetes appearing as the primary indexed condition, and to 2 interventions - of which GPT-based counseling is the first listed.
NCT06582719 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06582719 about?
NCT06582719 is a clinical study titled "Evaluating the Efficacy of GPT-based Nutrition and Diabetic Counseling in Gestational Diabetes Management: A Randomized Controlled Trial (AIM-GDM)". The purpose of this study is to assess whether an AI based counseling service can be beneficial for patients to assist in management of gestational diabetes.
What is the current status of trial NCT06582719?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-05-29. Estimated completion is 2027-01.
What conditions does trial NCT06582719 study?
This clinical trial studies the following conditions: Gestational Diabetes.
What interventions are being tested in trial NCT06582719?
The interventions under investigation include: GPT-based counseling (DEVICE), Nutritional Counseling (OTHER).
Who is sponsoring clinical trial NCT06582719?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06582719 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gestational Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06582719's enrollment target sits among peer trials
80 25th of 41 higher than 17 of 41 other Gestational Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gestational Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Nutrition Optimization and Community Upliftment for Postpartum Recovery
RECRUITING · NA
-
Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)
RECRUITING · NA
-
Delivering HOPE (Helping Women Optimize Prenatal Equity)
RECRUITING · NA
-
iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes
RECRUITING · NA
-
Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics
RECRUITING · NA
-
Preventing T2DM After GDM With Immediate Postpartum Screening
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI